...
首页> 外文期刊>Colloids and Surfaces, B. Biointerfaces >Effect of PEG molecular weight on stability, T2 contrast, cytotoxicity, and cellular uptake of superparamagnetic iron oxide nanoparticles (SPIONs)
【24h】

Effect of PEG molecular weight on stability, T2 contrast, cytotoxicity, and cellular uptake of superparamagnetic iron oxide nanoparticles (SPIONs)

机译:PEG分子量对超顺磁性氧化铁纳米粒子(SPIONs)的稳定性,T2对比度,细胞毒性和细胞摄取的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Superparamagnetic iron oxide nanoparticles (SPIONs) are currently unavailable as MRI contrast agents for detecting atherosclerosis in the clinical setting because of either low signal enhancement or safety concerns. Therefore, a new generation of SPIONs with increased circulation time, enhanced image contrast, and less cytotoxicity is essential. In this study, monodisperse SPIONs were synthesized and coated with polyethylene glycol (PEG) of varying molecular weights. The resulting PEGylated SPIONs were characterized, and their interactions with vascular smooth muscle cells (VSMCs) were examined. SPIONs were tested at different concentrations (100 and 500 ppm Fe) for stability, T_2 contrast, cytotoxicity, and cellular uptake to determine an optimal formulation for in vivo use. We found that at 100 ppm Fe, the PEG 2K SPIONs showed adequate stability and magnetic contrast, and exhibited the least cytotoxicity and nonspecific cellular uptake. An increase in cell viability was observed when the SPION-treated cells were washed with PBS after 1 h incubation compared to 5 and 24 h incubation without washing. Our investigation provides insight into the potential safe application of SPIONs in the clinic.
机译:由于信号增强低或出于安全考虑,目前超顺磁性氧化铁纳米颗粒(SPIONs)在临床环境中无法用作MRI造影剂来检测动脉粥样硬化。因此,具有延长的循环时间,增强的图像对比度和更少的细胞毒性的新一代SPIONs是必不可少的。在这项研究中,合成了单分散SPION,并用不同分子量的聚乙二醇(PEG)包被。表征所得的PEG化SPION,并检查它们与血管平滑肌细胞(VSMC)的相互作用。测试了SPIONs在不同浓度(100和500 ppm Fe)下的稳定性,T_2对比,细胞毒性和细胞摄取,以确定用于体内的最佳制剂。我们发现,在铁含量为100 ppm时,PEG 2K SPIONs表现出足够的稳定性和磁性对比,并且表现出最小的细胞毒性和非特异性细胞摄取。孵育1小时后,用PBS洗涤SPION处理的细胞,与不进行洗涤的5和24小时孵育相比,观察到细胞活力增加。我们的调查提供了SPIONs在临床中潜在安全应用的见识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号